Efforts to treat disorders like Lou Gehrig’s disease, Paget’s disease, inclusion body myopathy and dementia will receive a considerable boost from a new research model created by UC Irvine scientists.
UC Irvine scientists will be part of two research teams garnering CIRM Disease Team Therapy Development Awards, which are designed to accelerate collaborative translational research leading to human clinical trials.
Vinh Nguyen has proven himself a real problem solver.
Dr. Daniela Bota of UCI’s Comprehensive Brain Tumor Program is determined to find ways for cancer patients to avoid “chemo brain.”
UCI MIND hosts one of the field’s most influential annual Alzheimer’s disease research conferences featuring speakers and presentations showcasing the latest breakthroughs. Center director Frank LaFerla discusses the 2011 conference and exciting research and treatment efforts for the disease.
It will serve as clearinghouse for information, research and best practices.
Researchers with the Institute for Memory Impairments and Neurological Disorders (UCI MIND) have discovered how a novel compound can reduce the accumulation of brain plaques seen in Alzheimer’s disease without the side effects produced by any current drugs used for the chronic neurodegenerative disease.
The researchers identified a small protein called neuropeptide S that can strengthen and prolong memories of everything from negative events to simple objects.
Dr. Laura Mosqueda is a pioneer in the prevention of elder abuse
UCI’s Memory Assessment Clinic is the only outpatient facility in Orange County providing comprehensive services focused solely on the early identification of Alzheimer’s disease and related dementias.